Zydus Lifesciences announced that it has received a final approval from the United States Food and Drug Administration (USFDA) for its new drug application (NDA) to market Zituvimet XR(sitagliptin and metformin hydrochloride) tablets.
| Subscribe To Our Free Newsletter |
